Objectives: The mortality rate for patients with delirium tremens (DT) is 5%. As these patients present with elevated cardiac indices, coexisting DT in acute coronary syndrome (ACS) likely worsens outcomes. Our aim was to examine the outcomes of alcohol withdrawal syndrome (AWS) and DT in patients with ACS. Methods: We used the Nationwide Inpatient Sample (2000-2009) for our study. A multivariable logistic regression model was used to examine the independent association of AWS on inhospital mortality and a multivariable linear regression was used to examine the effect of AWS on inpatient length of stay (LOS). Results: An estimated 2,465,852 admissions with a primary diagnosis of ACS were analyzed. Of these, 4,499 patients had AWS and 3,460 patients had DT. Adjusting for age, gender, race, insurance, hospital characteristics, Charlson's comorbidity index, stent placement and year, the inhospital mortality was significant only for DT (OR 1.56; 95% CI 1.21-2.04). Inpatient LOS was 1.64 (95% CI 1.58-1.73) times higher in those with AWS and 2.33 (95% CI 2.22-2.43) times higher in DT when compared to nonalcoholics. Total hospital charges were higher for patients with AWS and DT when compared to nonalcoholics. Conclusions: Coexisting DT in ACS admissions is associated with increased mortality along with longer inpatient LOS and higher hospital costs.

Keywords:
Delirium tremens, Acute coronary syndrome, Alcohol withdrawal
1.
Kosten TR, O'Connor PG: Management of drug and alcohol withdrawal. N Engl J Med 2003;348:1786-1795.
2.
Yost DA: Alcohol withdrawal syndrome. Am Fam Physician 1996;54:657-664, 669.
3.
Abraham E, Shoemaker WC, McCartney SF: Cardiorespiratory patterns in severe delirium tremens. Arch Intern Med 1985;145:1057-1059.
4.
Sandoval Y, Smith SW, Thordsen SE, Apple FS: Supply/demand type 2 myocardial infarction: should we be paying more attention? J Am Coll Cardiol 2014;63:2079-2087.
5.
Introduction to the Healthcare Cost and Utlilization Project Nationwide Inpatient Sample, 2008. http://www.Hcup-us.Ahrq.Gov/db/nation/nis/nis_introduction_2008.Jsp (accessed July 23, 2014).
6.
Spies C, Tonnesen H, Andreasson S, Helander A, Conigrave K: Perioperative morbidity and mortality in chronic alcoholic patients. Alcohol Clin Exp Res 2001;25:164s-170s.
7.
Cuculi F, Kobza R, Ehmann T, Erne P: ECG changes amongst patients with alcohol withdrawal seizures and delirium tremens. Swiss Med Wkly 2006;136:223-227.
8.
Friesinger GC: Silent myocardial ischemia and the importance of coronary vasoconstriction. Curr Opin Cardiol 1989;4:492-498.
9.
Factor SM: Intramyocardial small-vessel disease in chronic alcoholism. Am Heart J 1976;92:561-575.
10.
Tan CH, Lee HS, Kua EH, Yeo B, Ang A: Difference in platelet cytosolic calcium response to thrombin in alcoholic withdrawal and sober patients. J Stud Alcohol 1995;56:21-23.
11.
Finn DA, Crabbe JC: Exploring alcohol withdrawal syndrome. Alcohol Health Res World 1997;21:149-156.
12.
Heard K, Palmer R, Zahniser NR: Mechanisms of acute cocaine toxicity. Open Pharmacol J 2008;2:70-78.
13.
Gottlieb LD: The role of beta-blockers in alcohol withdrawal syndrome. Postgrad Med 1988;spec:169-174.
14.
Carlson R, Keske B, Cortez A: Alcohol withdrawal syndrome: alleviating symptoms, preventing progression. J Crit Illn 1998;13:311-317.
15.
Coomes TR, Smith SW: Successful use of propofol in refractory delirium tremens. Ann Emerg Med 1997;30:825-828.
© 2015 S. Karger AG, Basel
2015
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
You do not currently have access to this content.